Stem cells as tools in regenerative therapy for retinal degeneration

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 563-571

  Enzmann, Volker ^a   Yolcu, Esma ^b   Kaplan, Henry J ^b   Ildstad, Suzanne T ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATION; CELL REGENERATION; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; NEURAL STEM CELL; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RETINA DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; HUMANS; PLURIPOTENT STEM CELLS; REGENERATION; REGENERATIVE MEDICINE; RETINA; RETINAL DEGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 65249170108     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.65     Document Type: Review

References (109)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
2. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of maculardegeneration. ProgRetin Eye Res. 2001;20(3):385-414.
3. Sippy BD, Hinton DR. Aging of retina and retinal pigment epithelium. In: Lim JI, ed. Age-Related Macular Degeneration. New York, NY: Marcel Dekker, Inc; 2002:1-14.
4. Kunze C, Elsner AE, Beausencourt E, Moraes L, HartnettME,Trempe CL. Spatial extent of pigmentepithelial detachments in age-related maculardegeneration. Ophthalmology. 1999;106(9):1830-1840.
5. Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. Oxidative damage in age-related macular degeneration. Histol Histopathol. 2007;22(12):1301-1308.
6. HeX, Hahn P, Iacovelli J, et al. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007;26(6):649-673.
7. Crabb JW, Miyagi M, Gu X, etal. Drusen proteome analysis: an approach to the etiology of age-related maculardegeneration. Proc Natl Acad Sci U S A. 2002; 99(23):14682-14687.
8. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002; 134(3):411-431.
9. TezelTH, BoraNS, Kaplan HJ. Pathogenesis of age-related maculardegeneration. Trends Mol Med. 2004;10(9):417-420.
10. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related maculardegeneration. Surv Ophthalmol. 2006; 51(2):137-152.
11. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes: short-term postoperative results. Ophthalmology. 1992;99(6):969-975, discussion 975-976.
12. Hsu JK, Thomas MA, Ibanez H, Green WR. Clinicopathologic studies of an eye aftersubmacularmembranectomyforchoroidal neovascularization. Retina. 1995; 15(1):43-52.
13. Nasir MA, Sugino I, Zarbin MA. Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration. Br J Ophthalmol. 1997;81(6):481-489.
14. Pollack JS, Del Priore LV, Smith ME, Feiner MA, Kaplan HJ. Postoperative abnormalities of the choriocapillaris in exudative age-related maculardegeneration. Br J Ophthalmol. 1996;80(4):314-318.
15. Postelmans L, Pasteels B, Coquelet P, El Ouardighi H, Verougstraete C, Schmidt- Erfurth U. Severe pigment epithelial alterations in the treatment area following photodynamic therapy forclassic choroidal neovascularization in young females. Am J Ophthalmol. 2004;138(5):803-808.
16. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2(pt 5):552-577.
17. Rosenfeld PJ, Brown DM, Heier JS, etal; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
18. Brown DM, Kaiser PK, Michels M, etal; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. NEnglJ Med. 2006;355(14):1432-1444.
19. Morris B, Imrie F, ArmbrechtAM, Dhillon B. Age-related maculardegeneration and recent developments: new hope for old eyes? Postgrad Med J. 2007; 83(979):301-307.
20. Del Priore LV, Geng L, Tezel TH, Kaplan HJ. Extracellular matrix ligands promote RPE attachment to inner Bruch's membrane. Curr Eye Res. 2002;25(2):79-89.
21. Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40(2):467-476.
22. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA. Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res. 2005; 80(2):235-248.
23. Phillips SJ, Sadda SR, Tso MO, Humayan MS, de Juan E Jr, Binder S. Autolo- gous transplantation of retinal pigment epithelium after mechanical debride- ment of Bruch's membrane. Curr Eye Res. 2003;26(2):81-88.
24. Sohocki MM, DaigerSP, Bowne SJ, et al. Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat. 2001;17(1):42-51.
25. Koenekoop RK, Lopez I, den Hollander AI, Allikmets R, Cremers FP. Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clin Experiment Ophthalmol. 2007;35(5):473-485.
26. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.
27. Ahmad I. Stem cells: new opportunities to treat eye diseases. Invest Ophthalmol Vis Sci. 2001;42(12):2743-2748.
28. Sagdullaev BT, Aramant RB, Seiler MJ, Woch G, McCall MA. Retinal transplantation-induced recovery of retinotectal visual function in a rodent model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2003;44(4):1686-1695.
29. TschernutterM, Schlichtenbrede FC, Howe S, etal. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus- mediated gene therapy. Gene Ther. 2005;12(8):694-701.
30. Wu WC, Lai CC, Chen SL, et al. Gene therapy for detached retina by adeno- associated virus vector expressing glial cell line-derived neurotrophic factor. Invest Ophthalmol Vis Sci. 2002;43(11):3480-3488.
31. Sieving PA, Caruso RC,Tao W, etal. Ciliary neurotrophic factor(CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA. 2006;103(10):3896-3901.
32. Perry D. Patients' voices: the powerful sound in the stem cell debate. Science. 2000;287(5457):1423.
33. Marshak DR, Gottleib D, Gardner RL. Stem cell biology. In: Marshak DR, Got- tleib D, Gardner RL, eds. Stem Cell Biology. Cold Spring Harbor, NY: CSHL Press; 2000:1-16.
34. Haruta M. Embryonic stem cells: potential source for ocular repair. Semin Ophthalmol. 2005;20(1):17-23.
35. Swijnenburg RJ,Tanaka M, Vogel H, etal. Embryonic stem cell immunogenic- ity increases upon differentiation aftertransplantation into ischemic myocardium. Circulation. 2005;112(9)(suppl):I166-I172.
36. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008;132(4):567-582.
37. Lavik EB, Klassen H, Warfvinge K, Langer R, Young MJ. Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials. 2005;26(16):3187-3196.
38. Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 1998; 95(23):13726-13731.
39. Thomson JA, Itskovitz-Eldor J, Shapiro SS, etal. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145-1147.
40. Hoffman LM, CarpenterMK. Characterization and culture of human embryonic stem cells. NatBiotechnol. 2005;23(6):699-708.
41. Arnhold S, Lenartz D, Kruttwig K, etal. Differentiation of green fluorescent protein- labeled embryonic stem cell-derived neural precursor cells into Thy-1-positive neurons and glia after transplantation into adult rat striatum. JNeurosurg. 2000; 93(6):1026-1032.
42. Brustle O, Jones KN, Learish RD, etal. Embryonic stem cell-derived glial precursors: asource of myelinating transplants. Science. 1999;285(5428):754-756.
43. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad SciUSA. 2002; 99(7):4391-4396.
44. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell- derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 2005;105(2):617-626.
45. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of car- diomyocytes derived from human embryonic stem cells. Circ Res. 2002; 91(6):501-508.
46. Rambhatla L, Chiu CP, Kundu P, Peng Y, CarpenterMK. Generation of hepatocyte- like cells from human embryonic stem cells. Cell Transplant. 2003;12(1): 1-11.
47. Winkler J, Hescheler J, Sachinidis A. Embryonic stem cells for basic research and potential clinical applications in cardiology. Biochim Biophys Acta. 2005; 1740(2):240-248.
48. Meyer JR. Human embryonic stem cells and respect for life. J Med Ethics. 2000; 26(3):166-170.
49. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? NatMed. 2001;7(4):393-395.
50. Lin H.Thetao of stem cells in the germline. Annu Rev Genet. 1997;31:455-491.
51. La PC. Cancer stem cells: lessons from melanoma [published online December 18, 2008]. StemCellRev. doi:10.1007/s12015-008-9048-7.
52. AsaharaT, KalkaC, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther. 2000;7(6):451-457.
53. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation(second of two parts). N Engl J Med. 1975;292(17):895-902.
54. Ratajczak MZ, KuciaM, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia. 2004; 18(1):29-40.
55. Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Tissue- specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis. 2004;32(1):52-57.
56. Caplice NM, Bunch TJ, Stalboerger PG, et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A. 2003;100(8):4754-4759.
57. Forbes SJ, Poulsom R, Wright NA. Hepatic and renal differentiation from blood- borne stem cells. Gene Ther. 2002;9(10):625-630.
58. Krause DS, Theise ND, Collector MI, etal. Multi-organ, multi-lineage engraft- ment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369-377.
59. Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003;100(3):1364-1369.
60. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701-705.
61. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science. 2000;288(5471):1660-1663.
62. McKay R. Stem cells in the central nervous system. Science. 1997;276(5309): 66-71.
63. Tropepe V, Coles BL, Chiasson BJ, et al. Retinal stem cells in the adult mammalian eye. Science. 2000;287(5460):2032-2036.
64. Oh H, Bradfute SB, Gallardo TD, etal. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 2003;100(21):12313-12318.
65. Hess D, Li L, Martin M, etal. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21(7):763-770.
66. Reca R, Mastellos D, Majka M, etal. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood. 2003;101(10):3784-3793.
67. Tsonis PA. Regenerative biology: the emerging field of tissue repair and restoration. Differentiation. 2002;70(8):397-409.
68. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res. 2003;58(2): 336-350.
69. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. ProcNatlAcadSciUSA. 2001: 98(18):10344-10349.
70. Kolb HJ, GuentherW, Gyurkocza B, etal. Tolerance and chimerism. Transplantation. 2003 75(9)(suppl):26S-31S.
71. Terada N, Hamazaki T, Oka M, etal. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416(6880):542- 545.
72. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002;416(6880):545-548.
73. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, etal. Fusion of bone-marrow- derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003:425(6961):968-973.
74. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol. 2004: 6(6):532-539.
75. Marin-Garcia J, Goldenthal MJ. Application of stem cells in cardiology: where we are and where we are going. CurrStem Cell Res Ther. 2006;1(1):1-11.
76. Xu YQ, Liu ZC. Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Rev. 2008;4(2):101-112.
77. Lowry NA, Temple S. Making human neurons from stem cells afterspinal cord injury. PLoSMed. 2007;4(2):e48.
78. Ramachandran AC, Bartlett LE, Mendez IM. A multiple target neural transplantation strategy for Parkinson's disease. Rev Neurosci. 2002;13(3):243-256.
79. Slavin S, Kurkalli BG, Karussis D. The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders. Clin Neurol Neurosurg. 2008;110(9):943-946.
80. Lund RD, Kwan AS, Keegan DJ, Sauve Y, Coffey PJ, Lawrence JM. Cell transplantation as a treatment for retinal disease. Prog Retin Eye Res. 2001;20 (4):415-449.
81. Ahmad I, Tang L, Pham H. Identification of neural progenitors in the adult mammalian eye. Biochem Biophys Res Commun. 2000;270(2):517-521.
82. Coles BL, Angenieux B, Inoue T, et al. Facile isolation and the characterization of human retinal stem cells. ProcNatlAcadSciUSA. 2004;101(44):15772-15777.
83. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by transplantation of photoreceptor precursors. Nature. 2006;444(7116):203- 207.
84. West EL, Pearson RA, Tschernutter M, Sowden JC, Maclaren RE, Ali RR. Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp Eye Res. 2008: 86(4):601-611.
85. Dong X, Pulido JS, Qu T, Sugaya K. Differentiation of human neural stem cells into retinal cells. Neuroreport. 2003;14(1):143-146.
86. Giordano F, De Marzo A, Vetrini F, Marigo V. Fibroblast growth factor and epidermal growth factor differently affect differentiation of murine retinal stem cells in vitro. MolVis. 2007;13:1842-1850.
87. Angénieux B, Schorderet DF, Arsenijevic Y. Epidermal growth factor is a neu- ronal differentiation factor for retinal stem cells in vitro. Stem Cells. 2006: 24(3):696-706.
88. BrabletzT, Hlubek F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs. 2005;179(1-2):56-65.
89. Hossain MA, Russell JC, Gomez R, Laterra J, Gomes R. Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB- independent [published correction appears in JNeurochem. 2002;81(4):901]. JNeurochem. 2002;81(2):365-378.
90. KorteGE, Reppucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984;25(10):1135-1145.
91. Li Y, Atmaca-Sonmez P, Schanie CL, Ildstad ST, Kaplan HJ, Enzmann V. Endogenous bone marrow derived cells express retinal pigment epithelium cell markersand migrate to focal areas of RPE damage. Invest Ophthalmol Vis Sci. 2007:48(9):4321-4327.
92. Enzmann V, RowBW, Yamauchi Y, etal. Behavioral and anatomical abnormalities in asodium iodate-induced model of retinal pigmentepithelium degeneration. ExpEye Res. 2006:82(3):441-448.
93. Kahn J, BykT, Jansson-Sjostrand L, etal. Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood. 2004;103(8):2942-2949.
94. Li Y, Reca R, Atmaca-Sonmez P, et al. Retinal pigment epithelium damage enhances expression of chemoattractsand migration of bone marrow-derived stem cells. Invest Ophthalmol Vis Sci. 2006;47(4):1646-1652.
95. Atmaca-Sonmez P, Li Y, Yamauchi Y, etal. Systemically transferred hematopoietic stem cells home to the subretinal space and express RPE-65 in a mouse model of retinal pigmentepithelium damage. Exp Eye Res. 2006;83(5):1295-1302.
96. Anderson DH, Guerin CJ, Erickson PA, Stern WH, Fisher SK. Morphological recovery in the reattached retina. Invest Ophthalmol Vis Sci. 1986;27(2):168-183.
97. Chiou SH, Kao CL, Peng CH, etal. A novel in vitro retinal differentiation model by co-culturing adult human bone marrow stem cells with retinal pigmented epithelium cells. Biochem Biophys Res Commun. 2005;326(3):578-585.
98. Haruta M, Sasai Y, Kawasaki H, et al. In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest Ophthalmol Vis Sci. 2004;45(3):1020-1025.
99. KuciaM, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of nonhematopoieticstem cells. Leukemia. 2005:19(7):1118-1127.
100. Kucia M, Zuba-Surma EK, Wysoczynski M, et al. Adult marrow-derived very small embryonic-like stem cells and tissue engineering. Expert Opin Biol Ther. 2007;7(10):1499-1514.
101. Kucia M, Wojakowski W, Reca R, etal. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch Immunol Ther Exp(Warsz). 2006;54(2): 121-135.
102. Marc RE, Jones BW, WattCB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003:22(5):607-655.
103. Tabata Y. Current status of regenerative medical therapy based on drug delivery technology. ReprodBiomedOnline. 2008;16(1):70-80.
104. Dawn B, Guo Y, Rezazadeh A, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res. 2006;98(8): 1098-1105.
105. Petit I, Szyper-Kravitz M, NaglerA, etal. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002:3(7):687-694.
106. Neipp M, ZorinaT, DomenickMA, Exner BG, Ildstad ST. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential. Blood. 1998;92(9):3177-3188.
107. Pituch-Noworolska A, MajkaM, Janowska-Wieczorek A, etal. Circulating CXCR4- positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity. Folia Histochem Cytobiol. 2003;41(1):13-21.
108. Singec I, Jandial R, Crain A, Nikkhah G, Snyder EY. The leading edge of stem cell therapeutics. AnnuRevMed. 2007;58:313-328.
109. Sharp J, Keirstead HS. Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells. Curr Opin Biotechnol. 2007: 18(5):434-440.